197

Drug Discovery
Sub Categories on Drug Discovery
Latest Articles
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea

FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea

by Lori SolomonThe U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.The first approval is forNuzolvence(zoliflodacin) gr

FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea

by Lori SolomonThe U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.The first approval is forNuzolvence(zoliflodacin) gr